Quantifying Conflict of Interest in the Choice of Anti-VEGF Agents
David J Browning,1 Paul B Greenberg2 1Charlotte, Eye, Ear, Nose, and Throat Associates, Charlotte, NC, 28210, USA; 2Division of Ophthalmology, Alpert Medical School, Brown University, Providence, RI, USACorrespondence: David J Browning Email djbrowning179@gmail.comPurpose: To quantify the economic i...
Enregistré dans:
Auteurs principaux: | Browning DJ, Greenberg PB |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c5e2e22f25dd4e10947d431574c45d58 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning
par: Miyamoto N, et autres
Publié: (2017) -
Gifts and Conflicts of Interest: In Shades of Gray?
par: Pasmanik Volochinsky,Diana, et autres
Publié: (2018) -
FINANCIAL AND NON-FINANCIAL CONFLICTS OF INTERESTS IN PSYCHIATRY
par: Maj,Mario
Publié: (2009) -
Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019:Funding and Conflicts of Interest
par: SHI Qianling, et autres
Publié: (2021) -
Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
par: Congxin Dai, et autres
Publié: (2021)